Role of immune-checkpoint inhibitors in lung cancer

Immune checkpoint inhibitors, mainly drugs targeting the programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) pathways, represent a remarkable advance in lung cancer treatment. Immune checkpoint inhibitors targeting PD-1 and PD-L1 are app...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Prantesh, Jain, Chhavi, Velcheti, Vamsidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937156/
https://www.ncbi.nlm.nih.gov/pubmed/29385894
http://dx.doi.org/10.1177/1753465817750075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937156/
https://www.ncbi.nlm.nih.gov/pubmed/29385894
http://dx.doi.org/10.1177/1753465817750075

Ejemplares similares